Diabetes and Bone Fragility: SGLT2 Inhibitor Use in the Context of Renal and Cardiovascular Benefits
Crossref DOI link: https://doi.org/10.1007/s11914-020-00609-z
Published Online: 2020-07-24
Published Print: 2020-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jackson, Kristen
Moseley, Kendall F. http://orcid.org/0000-0003-2500-2312
Text and Data Mining valid from 2020-07-24
Version of Record valid from 2020-07-24
Article History
First Online: 24 July 2020